BioSpace News Archive

Inogen, Inc. today announced financial results for the quarter ended September 30, 2022, and provided a business update.

Actinium Pharmaceuticals, Inc. today announced the appointment of Caroline Yarbrough as Chief Commercial Officer.

OrsoBio, Inc. today announced it has acquired exclusive worldwide rights to an ACC2 inhibitor program from Shionogi & Co., Ltd.

Lucid Diagnostics Inc. today announced that the Company will host a business update conference call and webcast on Monday, November 14, 2022, at 4:30 PM EDT.

Albireo Pharma, Inc. announced the completion of patient enrollment in the BOLD study, a global gold standard Phase 3 pivotal trial of Bylvay in 205 patients with biliary atresia over 24 months.

Evoke Pharma, Inc. today announced that the Company is scheduled to release its third quarter on Wednesday, November 9, 2022, after the market closes.

Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that the planned 1-for-3 reverse split of its common stock became effective after the close of business on Tuesday, November 1, 2022 (the “Effective Time”).

Thryv Therapeutics Inc. today announced two presentations on the results of SGK1 Inhibition in Patient- and Genotype Specific Re-Engineered Heart Cells with Congenital Long QT Syndrome and a model of Drug-Induced QT Prolongation at the American Heart Association Scientific Sessions 2022 taking place November 5-7, 2022, in Chicago, IL.

PharmAla Biotech (CSE:MDMA) is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug Administration (USFDA) in advance of its pre-IND meeting scheduled for later this month.

Turn Biotechnologies today announced it has appointed Richard “Ric” Peterson as chief financial officer.